Clinical Trial Update: Predicting SSRI Efficacy in Veterans With PTSD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether SSRIs predict efficacy in veterans with PTSD (with major depressive disorder) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Posttraumatic Stress Disorder

Drugs mentioned

• Selective serotonin reuptake inhibitors (SSRI)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Posttraumatic Stress Disorder, Major Depressive Disorder | Phase 4 | Status: TERMINATED